This proposal seeks to maintain and continue support for the Emory Neuroscience NINDS Core Facilities and provide consolidated resources and expertise to NINDS funded projects as well as projects aligned to the NINDS mission of reducing the burden of neurological diseases. There continues to be a great need for these core facilities at Emory given the dramatic growth of NINDS-funded research over the past decade. The Center will coordinate activities to provide shared core services for NINDS funded investigators. Generous institutional support, together with space and other resources available in the Center for Neurodegenerative Disease (CND), will be leveraged to provide access to the following shared cores: (1) Proteomics, (2) Imaging, (3) Neuropathology/Histochemistry, (4) Viral Vectors, and (5) Rodent behavior. These centralized services will enhance collaborative and multidisciplinary research, while providing strong support for junior faculty that is essential to sustain the NINDS mission. In addition to the services, the goal is to also provide outstanding administrative support for the Center by (a) facilitating, coordinating and monitoring access to the cores; (b) assisting with budgeting, reporting, and maintaining fiscal responsibility; and (c) providing an environment that fosters collaborative research utilizing state-of-the-art technologies and multidisciplinary approaches. Moreover, the Steering Committee (comprised of the Directors of the Center, the School of Medicine Dean for Research and the Directors of each of the Cores) will provide oversight of the operations of the cores, ensure compliance with NIH guidelines, establish priorities, and resolve any other issues that may arise. Emory Neuroscience NINDS Core Facilities has been a phenomenal success and is now an extremely valuable asset for the Emory neuroscience community as a whole and in particular for NINDS funded and junior faculty. We also believe it is essential for sustaining and promoting neuroscience investigations and collaborative ventures at Emory University.

Public Health Relevance

The primary objective of Emory Neuroscience NINDS Core Facilities or ENNCF is to enhance productivity, and collaborative and multidisciplinary research in neurological diseases at Emory University. The primary goal of this application is to provide centralized services (resources and expertise) that facilitate neurological research for Emory neuroscientists (NINDS and NINDS -aligned projects), including junior investigators. This will allow for efficient use of NINDS funds, maximize productivity and collaborations and accelerate the achievement of the NINDS mission of reducing the burden of neurological diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Center Core Grants (P30)
Project #
5P30NS055077-09
Application #
9506848
Study Section
Special Emphasis Panel (ZNS1)
Program Officer
Lavaute, Timothy M
Project Start
2008-04-01
Project End
2019-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
9
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Emory University
Department
Neurology
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Rangaraju, Srikant; Dammer, Eric B; Raza, Syed Ali et al. (2018) Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins. Mol Neurodegener 13:34
Ping, Lingyan; Duong, Duc M; Yin, Luming et al. (2018) Global quantitative analysis of the human brain proteome in Alzheimer's and Parkinson's Disease. Sci Data 5:180036
Rangaraju, Srikant; Dammer, Eric B; Raza, Syed Ali et al. (2018) Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease. Mol Neurodegener 13:24
Zhu, Dan; Osuka, Satoru; Zhang, Zhaobin et al. (2018) BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. Cancer Cell 33:1004-1016.e5
Pottier, Cyril; Zhou, Xiaolai; Perkerson 3rd, Ralph B et al. (2018) Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol 17:548-558
Umoh, Mfon E; Dammer, Eric B; Dai, Jingting et al. (2018) A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol Med 10:48-62
Omotade, Omotola F; Rui, Yanfang; Lei, Wenliang et al. (2018) Tropomodulin Isoform-Specific Regulation of Dendrite Development and Synapse Formation. J Neurosci 38:10271-10285
Johnson, Erik C B; Dammer, Eric B; Duong, Duc M et al. (2018) Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol Neurodegener 13:52
Srikanth, Priya; Lagomarsino, Valentina N; Pearse 2nd, Richard V et al. (2018) Convergence of independent DISC1 mutations on impaired neurite growth via decreased UNC5D expression. Transl Psychiatry 8:245
Abreha, Measho H; Dammer, Eric B; Ping, Lingyan et al. (2018) Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease. Proteomics 18:e1800108

Showing the most recent 10 out of 256 publications